AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11459288
Drug: Leukocyte-depleted erythrocyte
RxNorm normalized name: erythrocytes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukocyte-depleted erythrocyte suspensions (LD-SAGM)
Trial: 11459288
Drug: Non-leukocyte-depleted erythrocyte
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-leukocyte-depleted erythrocyte suspensions (SAGM)
Trial: 7870725
Drug: Local applications
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local applications of rifampicin and dimexide solutions
Trial: 24242334
Drug: Intravaginal progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravaginal progesterone implant between days 3 and 7 following fixed-time artificial insemination (FTAI)
Trial: 19157346
Drug: Tropisetron plus
RxNorm normalized name: tropisetron
DrugBank: Tropisetron (DB11699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron plus subhypnotic propofol infusion
Trial: 15034285
Drug: Low-dose omeprazole
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose omeprazole (L-OMP: 10 mg, q.d.)
Trial: 15034285
Drug: Standard-dose ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose ranitidine (S-H2RA: 150 mg, b.i.d.)
Trial: 3042835
Drug: rt-PA (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rt-PA (70 mg with an initial bolus of 10 mg)
Trial: 24968970
Drug: GTx‐758 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTx‐758 1000 mg/d
Trial: 24968970
Drug: GTx‐758 2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTx‐758 2000 mg/d
Trial: 24002501
Drug: Cabozantinib (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabozantinib (140 mg per day)
Trial: 24013610
Drug: Riluzole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riluzole (100 mg/day)
Trial: 6790966
Drug: Heparin-Dihydergot 2500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-Dihydergot 2500
Trial: 6790966
Drug: Conventional low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional low dose heparin regimen
Trial: 25022109
Drug: Domperidone, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone, 10 mg orally, three times a day for 4 sessions (5 days each session)
Trial: 23063071
Drug: Onartuzumab (MetMAb)
RxNorm normalized name: Onartuzumab
DrugBank: Onartuzumab (DB11746)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onartuzumab (MetMAb) plus erlotinib (150 mg oral daily)
Trial: 23063071
Drug: Erlotinib alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib alone (150 mg oral daily)
Trial: 19039022
Drug: Cpn10 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cpn10 (5 mg or 10 mg weekly for 12 weeks)
Trial: 17329479
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of memantine
Trial: 23384372
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of memantine
Trial: 10450451
Drug: Intradermal (i.d.)
RxNorm normalized name: IOBENGUANE I 123
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal (i.d.) administration of one-fifth dose of purified Vero-cell rabies vaccine (PVRV) with routine DTP-IPV vaccines (2, 3, 4 months)
Trial: 7846538
Drug: Standard combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard combination chemotherapy (cyclophosphamide/doxorubicin/vincristine)
Trial: 2129649
Drug: Colestipol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol 2.5 g b.d.
Trial: 2129649
Drug: Colestipol 5
RxNorm normalized name: colestipol 5 g oral granule for reconstitution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol 5 g b.d.
Trial: 2129649
Drug: Colestipol 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol 7.5 g b.d.
Trial: 6171687
Drug: Trimazosin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimazosin (300 mg single dose)
Trial: 22289389
Drug: Microwave energy
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microwave energy device treatment
Trial: 18431084
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of physical training and nutritional intervention
Trial: 18298870
Drug: No milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No milk supplement
Trial: 16117978
Drug: FF‐muG 130
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF‐muG 130 mg with food
Trial: 16117978
Drug: FF‐muG 130
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF‐muG 130 mg without food
Trial: 15247553
Drug: Atazanavir 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atazanavir 400 mg once daily
Trial: 14685054
Drug: Atazanavir 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atazanavir 600 mg once daily
Trial: 14685054
Drug: Nelfinavir 1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelfinavir 1250 mg twice a day
Trial: 10863994
Drug: High-salt diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-salt diet (HS; normal food plus NaCl 100 mg/kg per day)
Trial: 10863994
Drug: Acute oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute oral water load of 1500 ml
Trial: 1625504
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg o.m. for four weeks
Trial: 1625504
Drug: Omeprazole-treated patients
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole-treated patients re-examined 15 days after drug withdrawal
Trial: 6613908
Drug: Fatty fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fatty fish consumption (100 g or more at least twice a week for 3 months)
Trial: 24365194
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C infusion (3-g infusion within 6 hours before PCI)
Trial: 15668427
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg testosterone enanthate plus 1 mg daily of anastrozole (AT group, n = 19)
Trial: 15668427
Drug: Saline injection
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injection and placebo pill (placebo group, n = 21)
Trial: 23207959
Drug: Solifenacin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin (5 mg once daily)
Trial: 24465443
Drug: Rifabutin 150
RxNorm normalized name: rifabutin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifabutin 150 mg daily with lopinavir/ritonavir
Trial: 24465443
Drug: Rifabutin 150
RxNorm normalized name: rifabutin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifabutin 150 mg three times per week with lopinavir/ritonavir
Trial: 24465443
Drug: Rifabutin 300
RxNorm normalized name: Rifabutin
DrugBank: Rifabutin (DB00615)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifabutin 300 mg alone
Trial: 17696277
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg prednisolone daily (n = 34)
Trial: 16181540
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba extract injection (GB)
Trial: 9206242
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine alone
Trial: 16159821
Drug: Heparin-coated CPB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated CPB circuits
Trial: 1297896
Drug: New chewable,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New chewable, buffered ASA tablet formulation
Trial: 30664617
Drug: Bupropion-escitalopram combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion-escitalopram combination
Trial: 29522941
Drug: Venlafaxine-mirtazapine combination
RxNorm normalized name: Mirtazapine
DrugBank: Mirtazapine (DB00370)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine-mirtazapine combination
Trial: 24193291
Drug: Irsogladine maleate
RxNorm normalized name: maleate
DrugBank: Irsogladine (DB13056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irsogladine maleate (IM) 4 mg/body/day for two years
Trial: 24193291
Drug: Uracil-tegafur (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uracil-tegafur (250 mg/m2/day) for two years (Control)
Trial: 21367595
Drug: Erythromycin 250
RxNorm normalized name: erythromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 250 mg daily for 12 months
Trial: 16534529
Drug: Individualised Dietetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualised Dietetic Treatment (IDT)
Trial: 12927929
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily interferon (IFN)-beta (3 MU bid)
Trial: 12927929
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily interferon (IFN)-beta (6 MU qd)
Trial: 9326983
Drug: Intravenous sodium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sodium nitroprusside
Trial: 3358882
Drug: Intravenous nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous nifedipine
Trial: 3512747
Drug: Naproxen 5
RxNorm normalized name: naproxen 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 5 mg/kg twice daily for eight weeks
Trial: 27829454
Drug: 26-week dose
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 26-week dose reduction group (N = 120)
Trial: 27829454
Drug: No-dose-reduction group
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-dose-reduction group (N = 129)
Trial: 22086491
Drug: Progressive home-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progressive home-based strengthening exercise program (PHSEP) for 8 weeks in addition to weekly institutional exercise therapy
Trial: 22086491
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group continued weekly institutional exercise sessions
Trial: 20737957
Drug: Systemic medical
RxNorm normalized name: Vaginal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic medical treatment
Trial: 12393528
Drug: Iron chelation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron chelation treatment
Trial: 8791954
Drug: Amoxycillin 750
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 750 mg b.d. + omeprazole 40 mg b.d.
Trial: 8791954
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg b.d. + placebo
Trial: 12854150
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no specific treatment)
Trial: 3063044
Drug: Thiopentone 4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone 4.0 mg/kg i.v.
Trial: 30170904
Drug: Ambulatory oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambulatory oxygen treatment for 2 weeks
Trial: 30170904
Drug: No oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oxygen treatment for 2 weeks
Trial: 27075216
Drug: Proactive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proactive treatment group (intermittent preventive application of topical corticosteroid for 1 year)
Trial: 27075216
Drug: Proactive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proactive treatment group
Trial: 21855126
Drug: Nocturnal asthma
RxNorm normalized name: Nocdurna
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nocturnal asthma symptoms requiring albuterol (NASRAs)
Trial: 21855126
Drug: Nocturnal asthma
RxNorm normalized name: Nocdurna
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nocturnal asthma symptoms requiring albuterol (NASRAs) during exacerbation periods
Trial: 2234804
Drug: Topical dexamethasone
RxNorm normalized name: dexamethasone Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical dexamethasone drops
Trial: 355604
Drug: BCNU (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCNU (80 mg/sq m/day on 3 successive days every 6 to 8 weeks)
Trial: 31814226
Drug: Malic acid
RxNorm normalized name: Malic Acid
DrugBank: Malic acid (DB12751)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Malic acid lozenge
Trial: 22446490
Drug: Bupropion (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (150 mg)
Trial: 23052417
Drug: Bupropion (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (300 mg)
Trial: 10828671
Drug: Propiverine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propiverine (15 mg t.i.d.)
Trial: 10784360
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II pressor dose (1-3 microg/min)
Trial: 10784360
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II subpressor dose (0.0375-0.15 microg/min)
Trial: 10784360
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II pressor dose + Losartan (50 mg)
Trial: 10784360
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II subpressor dose + Losartan (50 mg)
Trial: 10583037
Drug: Placebo (electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (electrolyte solution)
Trial: 1833529
Drug: Meperidine (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine (12.5 mg every 5 minutes up to a maximum of 50 mg)
Trial: 8636581
Drug: Cardiovascular medications
RxNorm normalized name: CARDIOVASCULAR MEDICATIONS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiovascular medications
Trial: 28956671
Drug: Raw crushed
RxNorm normalized name: raw sugar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raw crushed garlic (100 mg/kg body weight, 2 times a day for 4 weeks)
Trial: 26615605
Drug: Spironolactone 100
RxNorm normalized name: spironolactone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 100 mg/day plus standard ADHF therapy
Trial: 26615605
Drug: Standard ADHF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard ADHF therapy alone
Trial: 17095117
Drug: Fluid Replacement
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid Replacement Trial (FR-trial) - water bolus (5.0 mL/kg body mass) ingested immediately pre-exercise and every 20 min during exercise (2.0 mL/kg body mass)
Trial: 10634370
Drug: Flutamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (250 mg/day)
Trial: 10661828
Drug: Finasteride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride (5 mg/day)
Trial: 10199771
Drug: Ketoconazole (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (300 mg/day)
Trial: 2242455
Drug: Surgeons who
RxNorm normalized name: sturgeon, unspecified preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgeons who offered a choice of treatment
Trial: 22180577
Drug: Combination pharmacotherapy
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination pharmacotherapy (bupropion, nicotine lozenge, nicotine patch, bupropion + lozenge, patch + lozenge)
Trial: 17934827
Drug: Concurrent immunomodulators
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent immunomodulators
Trial: 15901041
Drug: Sertraline hydrochloride
RxNorm normalized name: sertraline hydrochloride
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline hydrochloride 100 mg tablets (formulation 1)
Trial: 15901041
Drug: Sertraline hydrochloride
RxNorm normalized name: sertraline hydrochloride
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline hydrochloride 100 mg tablets (formulation 2)
Trial: 8750405
Drug: Bisoprolol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (2.5 to 10 mg/d)
Trial: 2027477
Drug: Phosphatidylserine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphatidylserine (100 mg BC‐PS tid)
Trial: 6487752
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release capsule (15 mg)
Trial: 29037240
Drug: KH176 single
RxNorm normalized name: KH176
DrugBank: Sonlicromanol (DB16333)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KH176 single dose of 800 mg
Trial: 29037240
Drug: KH176 multiple
RxNorm normalized name: KH176
DrugBank: Sonlicromanol (DB16333)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KH176 multiple doses of 400 mg b.i.d. for 7 days
Trial: 29037240
Drug: KH176 single
RxNorm normalized name: KH176
DrugBank: Sonlicromanol (DB16333)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KH176 single doses of 2000 mg
Trial: 29037240
Drug: KH176 pharmacokinetics
RxNorm normalized name: KH176
DrugBank: Sonlicromanol (DB16333)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KH176 pharmacokinetics
Trial: 29037240
Drug: KH176 renal
RxNorm normalized name: nirmatrelvir
DrugBank: Nirmatrelvir (DB16691)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: KH176 renal excretion
Trial: 15166533
Drug: Attention-control clinics
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Attention-control clinics (medication adherence)
Trial: 26871700
Drug: Intravitreal bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravitreal bevacizumab (BVB) 1.25 mg
Trial: 28098951
Drug: Web‐based feedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web‐based feedback on hazardous drug exposures plus tailored messages to address barriers
Trial: 26143313
Drug: IV morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV morphine 2 mg
Trial: 10376116
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V (250 mg orally twice daily for 4 months)
Trial: 29549067
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavioral therapy (iCBT) for 14 weeks
Trial: 15089890
Drug: Naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500 mg b.i.d.
Trial: 1606995
Drug: Alprazolam 1
RxNorm normalized name: alprazolam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam 1 mg alone
Trial: 1606995
Drug: Alprazolam 1
RxNorm normalized name: alprazolam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam 1 mg combined with alcohol 0.5 g/kg
Trial: 1606995
Drug: Placebo capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsule and alcohol 0.5 g/kg
Trial: 1606995
Drug: Placebo capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsule and placebo drink
Trial: 4020207
Drug: Levamisole (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (150 mg tablet once every fortnight)
Trial: 9322328
Drug: Chiropractic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiropractic treatment
Trial: 18394446
Drug: Unopposed micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unopposed micronized 17beta‐estradiol 1 mg/day
Trial: 28679502
Drug: Ibuprofen (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (400 mg every 4 hours)
Trial: 22459616
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg LGD-4033
Trial: 17707751
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg before the intervention, and 200 mg twice daily for 6 months after the procedure)
Trial: 17707751
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard care with aspirin and clopidogrel)
Trial: 11524058
Drug: rosuvastatin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 2.5 mg
Trial: 15063607
Drug: rosuvastatin 5
RxNorm normalized name: rosuvastatin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 5 mg
Trial: 26539650
Drug: rosuvastatin 40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 40 mg
Trial: 12505568
Drug: rosuvastatin 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 80 mg
Trial: 26539650
Drug: rosuvastatin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin (all doses)
Trial: 9284718
Drug: DHEA (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA (50 mg qd p.o. for four consecutive days starting two days before immunization)
Trial: 8313933
Drug: Deflazacort 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflazacort 60 mg/day
Trial: 8313933
Drug: Deflazacort 30
RxNorm normalized name: deflazacort 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflazacort 30 mg/day